Ignjatovic, Dejan <br/><br/>
Intra-abdominal administration of bevacizumab diminishes intra-peritoneal adhesions.  [electronic resource] 

 -  American journal of surgery  Aug 2010 
 - 270-5 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-1883 
<br/><br/><label>Standard No.: </label>10.1016/j.amjsurg.2009.08.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Disease Models, Animal<br/>Injections, Intraperitoneal<br/>Male<br/>Rats<br/>Rats, Wistar<br/>Tissue Adhesions--diagnosis<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors